Deep Track Capital’s Regulus Therapeutics RGLS Stock Holding History

Deep Track Capital’s Portfolio RGLS Stock Details RGLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-3,262,564	Closed	-$5.71M	–	74
2025 Q1	$5.71M	Hold	3,262,564	–	–	0.18%	58
2024 Q4	$5.15M	Hold	3,262,564	–	–	0.19%	56
2024 Q3	$5.12M	Hold	3,262,564	–	–	0.16%	62
2024 Q2	$5.82M	Sell	3,262,564 -4,002	-0.1%	-$9.29K	0.17%	55
2024 Q1	$9.41M	Buy	+3,266,566	New	+$5.33M	0.27%	53

Other funds holding RGLS

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Deep Track Capital's RGLS Position: Q2 2025 in Review

Deep Track Capital sold out of Regulus Therapeutics (RGLS) in Q2 2025, closing a stake of 3,262,564 shares — an estimated $5.71M sold.

Deep Track Capital first reported a position in RGLS in Q1 2024 and held it in 5 quarters. The position peaked at $9.41M in Q1 2024. 0 funds tracked by Wall St. Rank hold RGLS as of Q2 2025.

Deep Track Capital reported no remaining Regulus Therapeutics position as of Q2 2025 after selling out during the quarter.
Deep Track Capital sold 3,262,564 Regulus Therapeutics shares in Q2 2025, an estimated $5.71M.
Deep Track Capital first reported a position in Regulus Therapeutics in Q1 2024 and held it in 5 quarters.
Deep Track Capital's Regulus Therapeutics position peaked at $9.41M in Q1 2024.
0 funds tracked by Wall St. Rank held Regulus Therapeutics as of Q2 2025.

Based on Deep Track Capital's 13F filing for Q2 2025, filed 14 Aug 2025.